An NSF International Company

Industry news

NSF Health Sciences experts bring you the latest news updates from the industry

Draft SUPAC Manufacturing Equipment Addendum

Thursday the 4th April 2013

In April 2013 the FDA released a draft guidance of scale-up and post-approval changes that combines and supersedes the following previous SUPAC guidance documents:

  • SUPAC-IR/MR: Immediate Release and Modified Release Solid Oral Dosage Forms, Manufacturing Equipment Addendum
  • and SUPAC-SS Non-sterile Semi-solid Dosage Forms, Manufacturing Equipment Addendum.

The FDA stated that the new draft SUPAC addendum should be used in combination with the other SUPAC guidance documents.

This draft guidance removes the lists of manufacturing equipment that were in the previous guidance documents and clarifies the types of processes being referenced.

This draft guidance can be found at: Draft FDA SUPAC Equipment Addendum Apr 2013

    Quick links

    NSF Health Sciences have offices in Kirkbymoorside and Sheffield, UK and Washington and Ann Arbor, USA

    A word from NSF Health Sciences

    The legislation and guidance that apply to the healthcare industries is forever changing. NSF Health Sciences will provide you with regular updates on what is new and will also provide you with expert interpretation of these changes - what they mean

    Peter Gough

    © NSF Health Sciences 2015

    Registered Office: NSF Health Sciences, The Georgian House, 22/24 West End, Kirkbymoorside, York, UK, YO62 6AF
    Registered in England and Wales No: 3432550 | Tel: +44(0)1751 432999 | Fax: +44(0)1751 432450 | Email: [email protected]
    US Office: NSF Health Sciences, 2001 Pennsylvania Ave, NW, Suite 950, Washington DC 20006 | Tel: 1-202-822-1850 | Fax: 1-202-822-1859 | Email: [email protected]